ES2059132T3 - 2'-o-alquil-nucleotidos, asi como polimeros, que contienen tales nucleotidos. - Google Patents

2'-o-alquil-nucleotidos, asi como polimeros, que contienen tales nucleotidos.

Info

Publication number
ES2059132T3
ES2059132T3 ES91907452T ES91907452T ES2059132T3 ES 2059132 T3 ES2059132 T3 ES 2059132T3 ES 91907452 T ES91907452 T ES 91907452T ES 91907452 T ES91907452 T ES 91907452T ES 2059132 T3 ES2059132 T3 ES 2059132T3
Authority
ES
Spain
Prior art keywords
nucleotides
atom
equal
alkynil
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907452T
Other languages
English (en)
Inventor
Brian Sproat
Angus Lamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
European Molecular Biology Laboratory
Original Assignee
European Molecular Biology Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Molecular Biology Laboratory filed Critical European Molecular Biology Laboratory
Application granted granted Critical
Publication of ES2059132T3 publication Critical patent/ES2059132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fixing For Electrophotography (AREA)
  • Electrophotography Configuration And Component (AREA)
  • Color Electrophotography (AREA)

Abstract

LOS OLIGONUCLEOTIDOS CON LA FORMULA (II), EN LA QUE B SIGNIFICA UNA NUCLEOBASE CUALQUIERA, A ES IGUAL A O O CH2, X O Z ES O, S, NH O CH2, DONDE X Y Z PUEDEN SER IGUALES O DIFERENTES, V Y W SIGNIFICAN UN O, S, SE, NH2 O UN RADICAL ALQUILOXI, OH O SH, DONDE V Y W EN UNA UNIDAD MONOMERA PUEDEN SER IGUALES O DIFERENTES Y L ES UN ATOMO H O UN SOCIO DE UNA PAREJA DE ENLACE Y C ES IGUAL A CADO CON POR LO MENOS UN ATOMO DE C, O UN POSIBLE GRUPO ALQUENILO O ALQUINILO MODIFICADO CON AL MENOS DOS ATOMOS DE C, DONDE LA MODIFICACION EN UNA SUSTITUCION CONSTA DE UNO O VARIOS RADICALES HALOGENOS, CIANOS, CARBOXI, HIDROXI, NITRO O/Y MERCAPTO, SIENDO N UN NUMERO ENTERO CUALQUIERA, SON MUESTRAS ANTI-SENSE, ESTABLES Y LIGANTES ESPECIFICAMENTE. TALES OLIGO Y POLINUCLEOTIDOS ENCUENTRAN APLICACION PARA EL CONTROL DE LA EXPRESION GENETICA Y COMO MEDICAMENTO. SU SINTESIS SE REALIZA A PARTIR DE LOS MONOMEROS 2''-SUSTITUIDOS CORRESPONDIENTES, SEGUN PROCESOS YA CONOCIDOS, PREFERENTEMENTE EN UNA BASE SOLIDA.
ES91907452T 1990-04-09 1991-04-08 2'-o-alquil-nucleotidos, asi como polimeros, que contienen tales nucleotidos. Expired - Lifetime ES2059132T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011473 1990-04-09

Publications (1)

Publication Number Publication Date
ES2059132T3 true ES2059132T3 (es) 1994-11-01

Family

ID=6404077

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907452T Expired - Lifetime ES2059132T3 (es) 1990-04-09 1991-04-08 2'-o-alquil-nucleotidos, asi como polimeros, que contienen tales nucleotidos.

Country Status (8)

Country Link
EP (1) EP0524997B1 (es)
JP (1) JPH07103150B2 (es)
AT (1) ATE109788T1 (es)
CA (1) CA2080231C (es)
DE (2) DE4037363A1 (es)
DK (1) DK0524997T3 (es)
ES (1) ES2059132T3 (es)
WO (1) WO1991015499A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5623065A (en) * 1990-08-13 1997-04-22 Isis Pharmaceuticals, Inc. Gapped 2' modified oligonucleotides
US5955589A (en) * 1991-12-24 1999-09-21 Isis Pharmaceuticals Inc. Gapped 2' modified oligonucleotides
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US6358931B1 (en) 1990-01-11 2002-03-19 Isis Pharmaceuticals, Inc. Compositions and methods for modulating RNA
US5514786A (en) * 1990-01-11 1996-05-07 Isis Pharmaceuticals, Inc. Compositions for inhibiting RNA activity
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US6005087A (en) * 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US5670633A (en) * 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US6399754B1 (en) 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US7101993B1 (en) 1990-01-11 2006-09-05 Isis Pharmaceuticals, Inc. Oligonucleotides containing 2′-O-modified purines
US5965722A (en) * 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US7015315B1 (en) 1991-12-24 2006-03-21 Isis Pharmaceuticals, Inc. Gapped oligonucleotides
US7119184B2 (en) 1991-08-12 2006-10-10 Isis Pharmaceuticals, Inc. Oligonucleotides having A-DNA form and B-DNA form conformational geometry
US6307040B1 (en) 1992-03-05 2001-10-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
ATE515510T1 (de) * 1991-12-24 2011-07-15 Isis Pharmaceuticals Inc Durch dna-abschnitte unterbrochene modifizierte oligonukleotide
US6277603B1 (en) 1991-12-24 2001-08-21 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US5700922A (en) * 1991-12-24 1997-12-23 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US5856455A (en) * 1991-12-24 1999-01-05 Isis Pharmaceuticals, Inc. Gapped 2'-modified oligonucleotides
US5652355A (en) * 1992-07-23 1997-07-29 Worcester Foundation For Experimental Biology Hybrid oligonucleotide phosphorothioates
US6346614B1 (en) 1992-07-23 2002-02-12 Hybridon, Inc. Hybrid oligonucleotide phosphorothioates
ATE256143T1 (de) 1992-07-23 2003-12-15 Isis Pharmaceuticals Inc 2'-0-alkyl-nukleoside und-phosphoramidite, verfahren zu ihrer herstellung und ihre verwendungen
TW244371B (es) * 1992-07-23 1995-04-01 Tri Clover Inc
GB9304618D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
ES2203635T3 (es) * 1994-04-27 2004-04-16 Novartis Ag Nucleosidos y oligonucleotidos con grupos 2'-eter.
GB9417746D0 (en) * 1994-09-03 1994-10-19 Ciba Geigy Ag Chemical compounds
GB9417938D0 (en) * 1994-09-06 1994-10-26 Ciba Geigy Ag Compounds
DE69636160D1 (de) 1995-03-06 2006-06-29 Isis Pharmaceuticals Inc Verfahren zur synthese von 2'-0-substituierten pyrimidinen und oligomere davon
US6166197A (en) * 1995-03-06 2000-12-26 Isis Pharmaceuticals, Inc. Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
GB9606158D0 (en) * 1996-03-23 1996-05-29 Ciba Geigy Ag Chemical compounds
US5856099A (en) * 1996-05-21 1999-01-05 Isis Pharmaceuticals, Inc. Antisense compositions and methods for modulating type I interleukin-1 receptor expression
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
CA2256765A1 (en) 1996-06-06 1997-12-11 Novartis Ag 2'-substituted nucleosides and oligonucleotide derivatives
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
GB9612600D0 (en) 1996-06-13 1996-08-21 Ciba Geigy Ag Chemical compounds
US6576752B1 (en) 1997-02-14 2003-06-10 Isis Pharmaceuticals, Inc. Aminooxy functionalized oligomers
US6127533A (en) * 1997-02-14 2000-10-03 Isis Pharmaceuticals, Inc. 2'-O-aminooxy-modified oligonucleotides
US6172209B1 (en) 1997-02-14 2001-01-09 Isis Pharmaceuticals Inc. Aminooxy-modified oligonucleotides and methods for making same
WO2000040592A1 (en) * 1998-12-30 2000-07-13 Oligos Etc. Inc. Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
US8604183B2 (en) 2002-11-05 2013-12-10 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260032B1 (en) * 1986-09-08 1994-01-26 Ajinomoto Co., Inc. Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
FR2632955B1 (fr) * 1988-06-20 1991-12-27 Oris Ind Derives de nucleosides utilisables pour la synthese d'oligonucleotides marques, oligonucleotides obtenus a partir de ces derives et leur synthese
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
JPH0372493A (ja) * 1989-08-10 1991-03-27 Kikkoman Corp ２´―ｏ―置換―アデノシン―３´，５´―環状リン酸又はその塩の製法

Also Published As

Publication number Publication date
CA2080231A1 (en) 1991-10-10
EP0524997B1 (de) 1994-08-10
DK0524997T3 (da) 1995-01-02
CA2080231C (en) 2000-10-10
EP0524997A1 (de) 1993-02-03
ATE109788T1 (de) 1994-08-15
DE59102512D1 (de) 1994-09-15
JPH05505197A (ja) 1993-08-05
WO1991015499A1 (de) 1991-10-17
DE4037363A1 (de) 1991-10-10
JPH07103150B2 (ja) 1995-11-08

Similar Documents

Publication Publication Date Title
DK0524997T3 (da) 2-O-alkylnukleotider samt polymerer, som indeholder sådanne nukleotider
TW291486B (es)
NZ520071A (en) 4-aminopiperidine derivatives and their use as medicine
NL300159I1 (nl) Werkwijze voor het verwijderen van galzuren uit een patiënt en gealkyleerde samenstellingen daarvoor.
CA2296642A1 (en) Silicon-containing chain extenders
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
PL360880A1 (en) Use of trioxepans in the process to make high-solid acrylic, styrenic, and ldpe-type resins
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
IL103365A0 (en) Latent thiol mercaptan chain transfer agents and their use in the synthesis of polymers
CA2246909A1 (en) Method for chemical synthesis of oligonucleotides
IT1246265B (it) Componente solido di catalizzatore per la (co)polimerizzazione dell'etilene
DE69530512D1 (de) Phosphatase-aktivierte quervernetzende konjugierende und reduzierende agenzien, verfahren unter verwendung solcher agenzien und reagenzien die phosphatase-aktivierte quervernetzende und konjugierende agenzien enthalten
GR3004988T3 (es)
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
ATE155148T1 (de) Höheres alpha-olefincopolymerisat, verfahren zu seiner herstellung, daraus hergestelltes vulkanisiertes produkt und vulkanisierbare gummizusammensetzung
DK318885A (da) Polynukleotider, der er bundet kovalent til en fast baerer, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DE59309756D1 (de) 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
MA23129A1 (fr) Nouveaux derives de l'erythromycine,leur procede de preparatn et leur application
UA66748C2 (en) Phenyl substituted 4-azasteroids fluroderivatives, methods for the preparation thereof (variants) and pharmaceutical composition based thereon
IT9021711A0 (it) Componente solido di catalizzatore per la (co)polimerizzazione dell'etilene
SE8802574D0 (sv) Oligonucleotide hybridization probes and means for the synthesis of the most preferred probes
DE69600739D1 (de) Salpetersäureester von 2-(2,6-Dihalophenylamino) Phenylacetoessigsäurederivaten und Verfahren zu ihrer Herstellung
EP0401684A3 (de) Verfahren zur Herstellung von Organosiloxanen
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.
GB9612600D0 (en) Chemical compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 524997

Country of ref document: ES